Selective activation of NF‐κB and E2F by low concentration of arsenite in U937 human monocytic leukemia cells
- 1 March 2008
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 22 (2) , 136-146
Abstract
Arsenite has been reported to exert dose‐dependent dual effects: triggering apoptosis at relatively high concentrations, whereas inducing partial differentiation at low concentrations in leukemia cells. However, the relevant molecular mechanisms of its action at low and nonapoptotic concentrations remain to be elucidated. We examined the effect of arsenite on activation of key transcription factors in cultured U937 human monocytes/macrophages. Electrophoretic mobility shift assay (EMSA), protein/DNA array and luciferase reporter assay were used to analyze the effect of arsenite on the functional activities of transcription factors. Protein/DNA array analysis showed that activation of E2F was seen after 6‐h exposure to 1 and 10 μM arsenite. In contrast, activation of NF‐κB took place only at 1 μM arsenite, whereas 10 μM arsenite showed no recognizable effect on this nuclear transcription factor in the protein/DNA array analysis. EMSA using a NF‐κB consensus probe indicates the functional activation of RelB/p50 in the presence of 1 μM arsenite, confirming the above results. Luciferase reporter assay for NF‐κB showed activation of NF‐κB in the presence of 1 μM arsenite. Interleukin (IL)‐8 and B‐cell‐activating factor of the tumor necrosis factor family (BAFF) mRNA expression, which have been shown to be regulated through NF‐κB, were activated in the presence of 1 μM arsenite. These results support the hypothesis that the primary action of nonapoptotic concentrations of arsenite in this cell line is activation of NF‐κB, signaling as a decision maker for end results such as inflammation disease or cancer. This finding offers the possibility of providing a logical explanation for the observations made by many scientists that chronic exposure of human populations to low doses of arsenic is significantly correlated to clinical signs of inflammation in many tissues. © 2008 Wiley Periodicals, Inc. J Biochem Mol Toxicol 22:136–146, 2008; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20222Keywords
This publication has 30 references indexed in Scilit:
- RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated TranscriptionMolecular Endocrinology, 2007
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Protein-DNA Array-based Identification of Transcription Factor Activities Regulated by Interaction with the Glucocorticoid ReceptorJournal of Biological Chemistry, 2004
- 12-O-Tetradecanoylphorbol-13-acetate May Both Potentiate and Decrease the Generation of Apoptosis by the Antileukemic Agent Arsenic Trioxide in Human Promonocytic CellsJournal of Biological Chemistry, 2004
- Life and death decisions by E2F-1Cell Death & Differentiation, 2003
- E2F-1 Regulates Nuclear Factor-κB Activity and Cell AdhesionCirculation, 2002
- E2F1 pathways to apoptosisFEBS Letters, 2002
- E2F1 and c-Myc Potentiate Apoptosis through Inhibition of NF-κB Activity that Facilitates MnSOD-Mediated ROS EliminationMolecular Cell, 2002
- Activated Fes Protein Tyrosine Kinase Induces Terminal Macrophage Differentiation of Myeloid Progenitors (U937 Cells) and Activation of the Transcription Factor PU.1Molecular and Cellular Biology, 2002
- Arsenite Exposure of Cultured Airway Epithelial Cells Activates κB-dependent Interleukin-8 Gene Expression in the Absence of Nuclear Factor-κB Nuclear TranslocationJournal of Biological Chemistry, 1999